U.S. Pharmacist Weekly News

August 7, 2024

Study Finds CVD Risks Lower After COVID-19 Vaccination

Some vaccine-hesitant adults are worried that getting a COVID-19 vaccine will increase their risk of a stroke or other cardiovascular event. A new study of nearly the entire adult population of England found otherwise. Find out how researchers determined that COVID-19 vaccines lowered the risk of heart attacks and stroke overall for 46 million study participants.

Monitoring Prescribing of DOACs After Initial Prescription

One of the selling points for direct oral anticoagulants (DOACs) over older anticoagulants, such as warfarin, is that they require less monitoring. While that is generally true, according to authors of a new study, adverse events such as under- or over-prescribing of DOACs can be risky and usually occur after the initial prescription. These authors are calling for more monitoring. Read more.

Antiretroviral Drug Abacavir Found to Elevate CV Event Risk

The risk of major adverse cardiovascular (CV) events is increased by HIV patients treated with abacavir but no other antiretroviral drugs, according to a presentation at the 2024 International AIDS Conference in Munich, Germany. The researchers suggest that the introduction of newer antiretrovirals and longer-acting therapy should make it easier for clinicians to opt for other options. Read more.

How CGM Differs From BGM

The FreeStyle Libre 3 system has been cleared by the FDA and is indicated for use in people with diabetes aged 4 years and older. Learn more about the FreeStyle Libre 3 system and how it can be an effective tool for glucose monitoring in diabetes management.